Time-dependent effect of sevelamerHCl on the cardiovascular system.
Savica
Vincenzo
V
Monardo
Paolo
P
Santoro
Domenico
D
Mallamace
Agostino
A
Bellinghieri
Guido
G
D000368:Aged; D001774:Blood Chemical Analysis; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology; D002319:Cardiovascular System / Q000187:drug effects*; D015331:Cohort Studies; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D066298:In Vitro Techniques; D007676:Kidney Failure, Chronic / Q000628:therapy; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D011073:Polyamines / Q000009:adverse effects / Q000627:therapeutic use*; D011336:Probability; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D000069603:Sevelamer; D013997:Time Factors
D011073:Polyamines; D000069603:Sevelamer